Calton & Associates’s Innospec IOSP Stock Holding History

Calton & Associates’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-54	Closed	-$3K	–	804
2017 Q4	$3K	Buy	+54	New	+$3.6K	﹤0.01%	1330

Other funds holding IOSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

HCM

Huber Capital Management El Segundo, California $647M AUM 24.91% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Calton & Associates's IOSP Position: Q1 2018 in Review

Calton & Associates sold out of Innospec (IOSP) in Q1 2018, closing a stake of 54 shares — an estimated $3K sold.

Calton & Associates first reported a position in IOSP in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 176 funds tracked by Wall St. Rank hold IOSP as of Q1 2018.

Calton & Associates reported no remaining Innospec position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 54 Innospec shares in Q1 2018, an estimated $3K.
Calton & Associates first reported a position in Innospec in Q4 2017 and held it in 1 quarter.
Calton & Associates's Innospec position peaked at $3K in Q4 2017.
176 funds tracked by Wall St. Rank held Innospec as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.